N-(9-ethyl-9H-carbazol-3-yl)-3-oxobutanamide, 95.0%, 1g

3-Methyl-1,3-thiazolane-2,4-dione, 95.0%, 10g

DBD-PZ [=4-(N,N-Dimethylaminosulfonyl)-7-piperazino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

(4-Phenyl-piperazin-1-yl)-acetic acidhydrochloride, 98.0%, 50g

4-METHYL-3-PYRIDINEPROPANOIC ACID, 95.0%, 500mg

(R)-2-(3,3-dimethylureido)-2-phenylacetic acid, 95%, 1g

4-Methoxy-3-nitrobenzene-1-sulfonyl chloride, 95.0%, 5g

5-(2-Ethoxy-5-((4-(2-hydroxyethyl)piperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one, 95.0%, 1g

2,6-Dichloropyridine-3-carbonitrile, 97.0%, 100g

4-(methoxymethyl)-1-methyl-1H-pyrrole-2-carboxylic acid, 95.0%, 500mg

6-Bromo-2-chloroquinazolin-4-amine, 95.0%, 25g

Ethyl 5-(3,5-difluorophenyl)-5-oxovalerate, 97.0%, 1g

2-AMINO-5,6,7,8-TETRAHYDROQUINAZOLIN, 97.0%, 1g